Skip to main content
. 2024 Jul 29;34(5):491–496. doi: 10.1097/SLE.0000000000001308

TABLE 2.

Comparison of the Basic Characteristics and Tumor Features between the 2 Groups After PSM

Observed Indicators Group S N=75 Group A N=75 χ2/t P
Sex, male n (%) 42 (56.0) 43 (57.3) 0.027 0.869
Age (y) 61.83±10.45 62.31±13.11 −0.248 0.804
BMI(kg/m2) 23.79±2.73 23.57±3.10 0.453 0.651
History of smoking, n (%) 21 (28.0) 23 (30.7) 0.129 0.720
History of drinking, n (%) 7 (9.3) 16 (21.3) 4.160 0.041
Hypertension, n (%) 30 (40.0) 19 (25.3) 3.667 0.055
Diabetes, n (%) 12 (16.0) 6 (8.0) 2.273 0.132
cardiovascular disease, n (%) 9 (12.0) 7 (9.30) 0.280 0.597
Pathologic tumor size (cm) 2.01±1.21 2.05±0.96 −0.216 0.829
Location, n (%) 0.036 0.982
 Rectum 36 (48.0) 35 (46.7)
 Left hemi-colon 17 (22.7) 17 (22.7)
 Right hemi-colon 22 (29.3) 23 (30.7)
Morphology, n (%) 0.284 0.867
 0-I 18 (24.0) 16 (21.3)
 0-II/0-III 46 (61.3) 46 (61.3)
 SMTs 11 (14.7) 13 (17.3)
Pathologic diagnosis, n (%) 4.712 0.593
 Low-grade intraepithelial neoplasia 33 (44.0) 35 (46.7)
 High-grade intraepithelial neoplasia 18 (24.0) 14 (18.7)
 Intramucosal carcinoma 1 (1.3) 4 (5.30)
 Submucosal carcinoma 8 (10.7) 5 (6.7)
 Muscularis propria carcinoma 1 (1.3) 0 (0)
 NETs 9 (12.0) 13 (17.3)
 Others 5 (6.7) 4 (5.3)
Endoscopic resection of multiple lesions, n (%) 29 (38.76) 32 (42.7) 0.249 0.618

0–I indicates the morphology of the tumor is polypoid; 0–II/0–III, the morphology of the tumor is nonpolypoid; BMI, body mass index; ESD, endoscopic submucosal dissection; group A, patients undergoing colorectal ESD under general anesthesia; group S, patients undergoing colorectal ESD under conscious sedation; NET, neuroendocrine tumor; PSM, propensity score matching; SMT, submucosal tumor.